Search
Forte Biosciences Inc
FBRXAdd to Watchlist
76.600USD
-0.380-0.49%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.57BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Forte Biosciences Inc is 8.40, ranking 130 out of 385 in the Biotechnology & Medical Research industry. The average price target is 61.00, with a high of 75.00 and a low of 19.00.
Analyst Rating
Based on
5
analysts
Hold
Current Rating
73.800
Target Price
-3.66%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Forte Biosciences Inc
FBRX
5
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
Kymera Therapeutics Inc
KYMR
24
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Forte Biosciences Inc's price target?
Analysts forecast that Forte Biosciences Inc's price target is USD 61.00, with the highest forecast at USD 75.00 and the lowest forecast at USD 19.00.
How have Forte Biosciences IncFBRX's recent earnings per share performed?
The market expectation was USD -1.24, while Forte Biosciences IncFBRX's earnings per share (EPS) for the previous quarter was USD -1.39. EPS for the next quarter is expected at USD -0.88.
What is the analyst rating for Forte Biosciences Inc?
Based on the ratings of Forte Biosciences Inc's stock from 5 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.